Fri, January 5, 2024
Thu, January 4, 2024
Wed, January 3, 2024
Tue, January 2, 2024
Fri, December 29, 2023
Thu, December 28, 2023
Wed, December 27, 2023
Tue, December 26, 2023
Fri, December 22, 2023

Joel Beatty Initiated (AMLX) at Buy and Held Target at $37 on, Jan 3rd, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. t-buy-and-held-target-at-37-on-jan-3rd-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Joel Beatty of Baird, Initiated "Amylyx Pharmaceuticals, Inc." (AMLX) at Buy and Held Target at $37 on, Jan 3rd, 2024.

Joel has made no other calls on AMLX in the last 4 months.



There are 4 other peers that have a rating on AMLX. Out of the 4 peers that are also analyzing AMLX, 0 agree with Joel's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Joel


  • Graig Suvannavejh of "Mizuho" Maintained at Strong Buy with Decreased Target to $27 on, Thursday, December 21st, 2023
  • Neena Bitritto-Garg of "Deutsche Bank" Initiated at Strong Buy and Held Target at $36 on, Tuesday, December 12th, 2023
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $42 on, Friday, November 10th, 2023
  • Chris Shibutani of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $40 on, Friday, November 10th, 2023

Publication Contributing Sources